People Who Are Moderately or Severely Immunocompromised: Completed the Initial Series Before 2024-2025 Vaccine
Should receive 2 doses of an age-appropriate COVID-19 vaccine*
- Administer the first dose at least 8 weeks after the last dose
- Administer the next dose 6 months after 2024-2025 Dose 1+
May receive additional age-appropriate 2024-2025 COVID-19 vaccine doses under shared clinical decision-making*
*Children 6 months through 4 years should receive all doses from the same manufacturer
+Minimum interval 8 weeks
Reference: Interim Clinical Considerations for Use of COVID-19 Vaccines | CDC and 2024-2025 COVID-19 Vaccine Immunization Schedule for People 6 Months of Age and Older (cdc.gov)
Page last reviewed: November 12, 2024
Content source: National Center for Immunization and Respiratory Diseases